<DOC>
	<DOCNO>NCT00680160</DOCNO>
	<brief_summary>The purpose study determine absorption , systemic pharmacokinetics accumulation nail AN2690 28 day period daily application 7.5 % solution AN2690 10 toenail 25 otherwise healthy adult patient onychomycosis .</brief_summary>
	<brief_title>Absorption Systemic Study AN2690 Patients With Moderate Severe Onychomycosis ( ADME I )</brief_title>
	<detailed_description>For study , case definition onychomycosis include moderate severe distal subungual onychomycosis include subject evidence subungual dermatophytoma yellow spike , lateral proximal onychomycosis severely dystrophic nail plate . Subjects superficial white onychomycosis exclude . Confirmation clinical diagnosis onychomycosis least one great toenail include positive KOH wet mount .</detailed_description>
	<mesh_term>Onychomycosis</mesh_term>
	<mesh_term>Tavaborole</mesh_term>
	<criteria>A witnessed , sign informed consent approve Institutional Review Board Male female race least 18 year age old 65 year age time screen Body Mass Index 18.5 35 , inclusive Onychomycosis involve &gt; 80 % great toenail , determine visual inspection nail trim Each great toenail posse combine thickness nail plate nail bed &gt; 3 mm At least six additional toenail clinical diagnosis onychomycosis A positive KOH wet mount least one great toenail If subject female childbearing potential , must use highly effective method birth control ( e.g . implant , injectables , combine oral contraceptive , intrauterine contraceptive device ) study Considered reliable capable understand his/her responsibility role study History allergy test product ( ) components test product ( ) history hypersensitivity allergic reaction study preparation describe Investigator 's Brochure Clinically significant laboratory abnormality would interfere conduct interpretation study jeopardize his/her safety Diabetes mellitus require treatment diet exercise Unwilling refrain use nail cosmetic clear color nail lacquer screen visit end study Nursing , pregnant planning become pregnant study Has undergone specify washout period ( ) follow topical preparation subject require concurrent use follow topical medication : 1 . Topical antifungal apply foot ( include antifungal treatment T. pedis study : 4 week 2 . Antiinflammatories , corticosteroid , topical immunomodulators : 2 week Has undergone specify washout period ( ) follow systemic medication subject require concurrent use follow systemic medication : 1 . Corticosteroids ( include intramuscular injection ) : 2 week 2 . Antifungals treatment onychomycosis systemic antifungal know activity dermatophyte : 24 week 3 . Systemic immunomodulators : 4 week Received treatment type cancer within last 6 month History significant internal disease Nail anatomic abnormality toe , e.g. , genetic nail disorder , primentary disorder , onychogryphosis , trauma nail ( ) treat AIDS AIDS relate complex History street drug alcohol abuse Donated lose blood , participate clinical study involve withdrawal large volume blood ( 480 mL ) , six week period precede study initiation Donated plasma two week period precede study initiation Participated trial investigational drug device within 60 day prior enrollment participation research study concurrent study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Onychomycosis</keyword>
	<keyword>Fungal Nail</keyword>
</DOC>